GEODE CAPITAL MANAGEMENT, LLC
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in RYTM
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$123,172,914
-$24,085,117 QoQ
Shares Held
1,416,269
+2.9% QoQ
Ownership
2.07%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,556,460,669 across 523 Biotechnology names. RYTM ranks #30 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in RYTM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $123,172,914 | 1,416,269 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $147,258,031 | 1,375,729 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $137,632,100 | 1,362,829 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $82,858,076 | 1,311,253 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $68,181,287 | 1,287,168 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $70,299,627 | 1,255,799 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $65,811,688 | 1,256,188 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $51,435,410 | 1,252,689 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $51,159,947 | 1,180,705 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $51,446,360 | 1,119,129 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $23,957,931 | 1,045,057 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,050,541 | 973,350 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,434,056 | 472,761 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $13,351,811 | 458,510 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,508,744 | 388,112 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,659,145 | 399,794 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,535,041 | 740,889 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,125,999 | 714,028 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $8,719,613 | 667,658 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $13,410,400 | 684,903 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $13,263,163 | 623,562 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $14,521,529 | 488,447 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $10,654,683 | 491,679 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,631,525 | 476,750 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,746,371 | 443,257 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||